Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Status: Enrolling
Updated:  8/11/2015
Novartis Investigative Site
mi
from
Lake Jackson, TX
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Status: Enrolling
Updated: 8/11/2015
Novartis Investigative Site
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Status: Enrolling
Updated:  8/11/2015
Novartis Investigative Site
mi
from
Richmond, VA
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Status: Enrolling
Updated: 8/11/2015
Novartis Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Status: Enrolling
Updated:  8/11/2015
Novartis Investigative Site
mi
from
Charleston, WV
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Status: Enrolling
Updated: 8/11/2015
Novartis Investigative Site
mi
from
Charleston, WV
Click here to add this to my saved trials
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Status: Enrolling
Updated:  8/11/2015
Novartis Investigative Site
mi
from
Caba,
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension
Status: Enrolling
Updated: 8/11/2015
Novartis Investigative Site
mi
from
Caba,
Click here to add this to my saved trials
The Effect of Phentermine and B12 on Weight Loss Among Obese Patients
A Pilot Study to Assess Whether the Combination of Phentermine and B12 Has a Significant Effect on Weight Loss Among an Obese Study Population
Status: Enrolling
Updated:  8/11/2015
Brody Outpatient of Brody Medical Sciences Module D
mi
from
Greenville, NC
The Effect of Phentermine and B12 on Weight Loss Among Obese Patients
A Pilot Study to Assess Whether the Combination of Phentermine and B12 Has a Significant Effect on Weight Loss Among an Obese Study Population
Status: Enrolling
Updated: 8/11/2015
Brody Outpatient of Brody Medical Sciences Module D
mi
from
Greenville, NC
Click here to add this to my saved trials
Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
Status: Enrolling
Updated:  8/13/2015
Cardiovascular Genetics, University of Utah
mi
from
Salt Lake City, UT
Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
Status: Enrolling
Updated: 8/13/2015
Cardiovascular Genetics, University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults
The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults (S31)
Status: Enrolling
Updated:  8/13/2015
Purdue University
mi
from
West Lafayette, IN
The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults
The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults (S31)
Status: Enrolling
Updated: 8/13/2015
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
One-Day Acceptance and Commitment Training Intervention in Primary Care Patients
One-Day Acceptance and Commitment Training Intervention in Primary Care Patients
Status: Enrolling
Updated:  8/13/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
One-Day Acceptance and Commitment Training Intervention in Primary Care Patients
One-Day Acceptance and Commitment Training Intervention in Primary Care Patients
Status: Enrolling
Updated: 8/13/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
Status: Enrolling
Updated:  8/17/2015
UNC Chapel Hill
mi
from
CHapel Hill, NC
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
Status: Enrolling
Updated: 8/17/2015
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients
Status: Enrolling
Updated:  8/18/2015
Hunter College of the City University of New York
mi
from
New York, NY
Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients
Status: Enrolling
Updated: 8/18/2015
Hunter College of the City University of New York
mi
from
New York, NY
Click here to add this to my saved trials
Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients
Status: Enrolling
Updated:  8/18/2015
Mount Sinai St. Luke's
mi
from
New York, NY
Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients
Status: Enrolling
Updated: 8/18/2015
Mount Sinai St. Luke's
mi
from
New York, NY
Click here to add this to my saved trials
Veterans Walk for Health Study
Does Step Count Feedback Enhance Counseling for Weight Loss?
Status: Enrolling
Updated:  8/19/2015
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Veterans Walk for Health Study
Does Step Count Feedback Enhance Counseling for Weight Loss?
Status: Enrolling
Updated: 8/19/2015
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Renal Artery Contrast-Free Trial
Comparison of Non-contrast Renal Artery Magnetic Resonance Angiography With Contrast-enhanced CT Angiography
Status: Enrolling
Updated:  8/24/2015
Central Coast Cardiolgy
mi
from
Salinas, CA
Renal Artery Contrast-Free Trial
Comparison of Non-contrast Renal Artery Magnetic Resonance Angiography With Contrast-enhanced CT Angiography
Status: Enrolling
Updated: 8/24/2015
Central Coast Cardiolgy
mi
from
Salinas, CA
Click here to add this to my saved trials
Improving Hypertension Control
Status: Enrolling
Updated:  8/24/2015
Hillside Family Health Center
mi
from
Milwaukee, WI
Improving Hypertension Control
Status: Enrolling
Updated: 8/24/2015
Hillside Family Health Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Improving Hypertension Control
Status: Enrolling
Updated:  8/24/2015
Lisbon Avenue Health Center
mi
from
Milwaukee, WI
Improving Hypertension Control
Status: Enrolling
Updated: 8/24/2015
Lisbon Avenue Health Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Reducing Risk of Recurrence
Reducing Risk of Recurrences: Issues in Maintenance and Stability in Stroke (CDA 08-009)
Status: Enrolling
Updated:  8/25/2015
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
mi
from
New York, NY
Reducing Risk of Recurrence
Reducing Risk of Recurrences: Issues in Maintenance and Stability in Stroke (CDA 08-009)
Status: Enrolling
Updated: 8/25/2015
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
mi
from
New York, NY
Click here to add this to my saved trials
ActiV.A.C.+ Compression Therapy Versus Compression Therapy Alone for the Treatment of Chronic Venous Ulcerations
A Prospective, Randomized, Comparative Effectiveness Trial of the ActiV.A.C.+ Compression Therapy Versus Compression Therapy Alone for the Treatment of Chronic Venous Ulcerations
Status: Enrolling
Updated:  8/25/2015
Georgetown University Hospital Center for Wound Healing
mi
from
Washington,
ActiV.A.C.+ Compression Therapy Versus Compression Therapy Alone for the Treatment of Chronic Venous Ulcerations
A Prospective, Randomized, Comparative Effectiveness Trial of the ActiV.A.C.+ Compression Therapy Versus Compression Therapy Alone for the Treatment of Chronic Venous Ulcerations
Status: Enrolling
Updated: 8/25/2015
Georgetown University Hospital Center for Wound Healing
mi
from
Washington,
Click here to add this to my saved trials
The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes
The Effect of Medication Reminder Technology on Medication Adherence and Hypertension
Status: Enrolling
Updated:  8/26/2015
Purdue University
mi
from
West Lafayette, IN
The Effect of Medication Reminder Technology on Medication Adherence and Hypertension Outcomes
The Effect of Medication Reminder Technology on Medication Adherence and Hypertension
Status: Enrolling
Updated: 8/26/2015
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated:  8/31/2015
Lexicon Investigational Site
mi
from
Morrow, GA
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated: 8/31/2015
Lexicon Investigational Site
mi
from
Morrow, GA
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated:  8/31/2015
Lexicon Investigational Site
mi
from
Memphis, TN
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated: 8/31/2015
Lexicon Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated:  8/31/2015
Lexicon Investigational Site
mi
from
Austin, TX
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated: 8/31/2015
Lexicon Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated:  8/31/2015
Lexicon Investigational Site
mi
from
Houston, TX
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated: 8/31/2015
Lexicon Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated:  8/31/2015
Lexicon Investigational Site
mi
from
San Antonio, TX
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated: 8/31/2015
Lexicon Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
A Phase 3 Open-label Multi-Center, Two-Part Single-arm Study to Evaluate the Acute Vasodilation Response of Inhaled Nitric Oxide as a Predictor of Successful Wean From Parental Prostacyclins in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/3/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
A Phase 3 Open-label Multi-Center, Two-Part Single-arm Study to Evaluate the Acute Vasodilation Response of Inhaled Nitric Oxide as a Predictor of Successful Wean From Parental Prostacyclins in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/3/2015
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
A Phase 3 Open-label Multi-Center, Two-Part Single-arm Study to Evaluate the Acute Vasodilation Response of Inhaled Nitric Oxide as a Predictor of Successful Wean From Parental Prostacyclins in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  9/3/2015
University of Alabama
mi
from
Birmingham, AL
Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide
A Phase 3 Open-label Multi-Center, Two-Part Single-arm Study to Evaluate the Acute Vasodilation Response of Inhaled Nitric Oxide as a Predictor of Successful Wean From Parental Prostacyclins in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 9/3/2015
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Improving Outcomes for Hypertensive Children
Improving Outcomes for Hypertensive Children
Status: Enrolling
Updated:  9/8/2015
Arkansas Children's Hospital
mi
from
Little Rock, AR
Improving Outcomes for Hypertensive Children
Improving Outcomes for Hypertensive Children
Status: Enrolling
Updated: 9/8/2015
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Louisville, KY
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Metairie, LA
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Baltimore, MD
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Tulsa, OK
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Dallas, TX
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Norfolk, VA
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Huntsville, AL
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Muscle Shoals, AL
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Glendale, AZ
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Glendale, AZ
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Greenbrae, CA
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Santa Ana, CA
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Denver, CO
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
DeLand, FL
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Miami, FL
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Palm Harbor, FL
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Port Orange, FL
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Marietta, GA
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Gurnee, IL
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Gurnee, IL
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Wichita, KA
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated:  9/8/2015
Clinical Research Facility
mi
from
Auburn, ME
Perindopril Amlodipine for the Treatment of Hypertension
Perindopril Amlodipine for the Treatment of Hypertension (PATH): A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Efficacy and Safety of a Fixed-Dose Combination of Perindopril Arginine Plus Amlodipine Besylate Versus Perindopril Erbumine and Amlodipine Besylate in Subjects With Essential Hypertension
Status: Enrolling
Updated: 9/8/2015
Clinical Research Facility
mi
from
Auburn, ME
Click here to add this to my saved trials